Dr. Marks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5115 Centre Ave
3rd Floor
Pittsburgh, PA 15232Phone+1 412-235-1077Fax+1 412-235-1030
Summary
- Dr. Stanley Marks is an oncologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian, Shadyside Campus, and UPMC Magee-Womens Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 44 years. He is experienced in hematologic oncology and acute myeloid leukemia.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1978
UPMC Medical EducationResidency, Internal Medicine, 1973 - 1976
University of Pittsburgh School of MedicineClass of 1973
Certifications & Licensure
PA State Medical License 1974 - 2024
OH State Medical License 1991 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.Jacqueline C Barrientos, Ayed O Ayed, Agnes Cha, Senxi Du, Bruno Fang
Targeted Oncology. 2023-09-01 - 41 citationsProspective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in t...Ghady Haidar, Mounzer Agha, Andrew Bilderback, Amy Lukanski, Kelsey Linstrum
Clinical Infectious Diseases. 2022-08-24 - 32 citationsPembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis.Chaoyuan Kuang, Yongseok Park, Ryan C Augustin, Yan Lin, Douglas J Hartman
Clinical Epigenetics. 2022-01-06
Press Mentions
National Drug Shortage Impacting Cancer Care at UPMCMay 25th, 2023- Satchels of Caring Foundation Closing After Nearly 2 Decades Giving Hope to Cancer PatientsFebruary 22nd, 2022
- Health Experts Say Evusheld Is Effective Against Fighting COVID-19February 1st, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
